University of Kansas Cancer Center Post San Antonio Review

 

University of Kansas Cancer Center Post San Antonio Review
S

SABCS Updates on HR+, HER2- MBC: What Is the Role of HDACi? Does Intrinsic Subtype Predict Benefit to CDK4/6i? Is There a Role for Oral Taxanes? How Effective Are PI3Ki?

By University of Kansas Cancer Center Post San Antonio Review FEATURING Sara Tolaney
By University of Kansas Cancer Center Post San Antonio Review FEATURING Sara Tolaney
189 views
February 28, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy
2021
14:39

What's New in HER2+ MBC Targeted Therapy: Efficacy Analysis of Oral …

University of Kansas Cancer Center Post San Antonio Review

H. McArthur

380 views
16:19

2021 Changing Treatment Paradigms for HER2+ mBC: Expert Efficacy Ana…

University of Kansas Cancer Center Post San Antonio Review

H. McArthur

198 views
14:55

50 y/o Premenopausal Woman With T2N1mic BC: Would You Order Gene Exp…

University of Kansas Cancer Center Post San Antonio Review

P. Sharma, S. Tolaney, I. Mayer, Q. Khan, J. Balko

67 views
14:05

Challenging Cases of BC: What Should Be the Next Line of Therapy for…

University of Kansas Cancer Center Post San Antonio Review

P. Sharma, S. Tolaney, I. Mayer, Q. Khan, J. Balko

320 views
12:04

48 y/o PALB2 Mutation Carrier With T2N0 ER/PR+, HER2- BC: How to Cou…

University of Kansas Cancer Center Post San Antonio Review

P. Sharma, J. Klemp, H. McArthur, S. Domchek

273 views
08:29

42 y/o With cT2N Grade III TNBC: Does Inclusion of CPIs & Carboplati…

University of Kansas Cancer Center Post San Antonio Review

P. Sharma, J. Klemp, H. McArthur, S. Domchek

161 views
07:56

Expert Discussion on Challenging BC Cases: What Treatment Option to …

University of Kansas Cancer Center Post San Antonio Review

P. Sharma, J. Klemp, H. McArthur, S. Domchek

177 views
19:16

BC Predisposition Genes San Antonio Review: Who to Test? Should the …

University of Kansas Cancer Center Post San Antonio Review

S. Domchek

97 views
17:29

SABCS Updates on HR+, HER2- MBC: What Is the Role of HDACi? Does Int…

University of Kansas Cancer Center Post San Antonio Review

S. Tolaney

189 views
07:53

SABCS Data on mTNBC: 1L Chemo + IO in PD-L1+ Disease, Sacituzumab Go…

University of Kansas Cancer Center Post San Antonio Review

S. Tolaney

225 views
21:41

Endocrine Resistance in BC: Mechanisms and Treatment Strategies

University of Kansas Cancer Center Post San Antonio Review

J. Balko

142 views
31:02

Genomic Signatures in Adjuvant Therapy of HR+ EBC: Should We Conside…

University of Kansas Cancer Center Post San Antonio Review

I. Mayer

212 views
27:20

Predictive & Prognostic Biomarkers in Neoadjuvant TNBC: How Valuable…

University of Kansas Cancer Center Post San Antonio Review

A. Bardia

376 views